JP2005517643A5 - - Google Patents

Download PDF

Info

Publication number
JP2005517643A5
JP2005517643A5 JP2003549322A JP2003549322A JP2005517643A5 JP 2005517643 A5 JP2005517643 A5 JP 2005517643A5 JP 2003549322 A JP2003549322 A JP 2003549322A JP 2003549322 A JP2003549322 A JP 2003549322A JP 2005517643 A5 JP2005517643 A5 JP 2005517643A5
Authority
JP
Japan
Prior art keywords
alkyl
group
substituted
unsubstituted
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003549322A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005517643A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/036128 external-priority patent/WO2003048130A2/en
Publication of JP2005517643A publication Critical patent/JP2005517643A/ja
Publication of JP2005517643A5 publication Critical patent/JP2005517643A5/ja
Pending legal-status Critical Current

Links

JP2003549322A 2001-11-30 2002-11-26 ペルオキシソーム増殖因子活性化受容体アゴニスト Pending JP2005517643A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33445301P 2001-11-30 2001-11-30
PCT/US2002/036128 WO2003048130A2 (en) 2001-11-30 2002-11-26 Peroxisome proliferator activated receptor agonists

Publications (2)

Publication Number Publication Date
JP2005517643A JP2005517643A (ja) 2005-06-16
JP2005517643A5 true JP2005517643A5 (enExample) 2006-01-05

Family

ID=23307275

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003549322A Pending JP2005517643A (ja) 2001-11-30 2002-11-26 ペルオキシソーム増殖因子活性化受容体アゴニスト

Country Status (19)

Country Link
US (1) US7544812B2 (enExample)
EP (1) EP1453811A2 (enExample)
JP (1) JP2005517643A (enExample)
KR (1) KR20050044606A (enExample)
CN (1) CN1582279A (enExample)
AU (1) AU2002356927A1 (enExample)
BR (1) BR0214437A (enExample)
CA (1) CA2468846A1 (enExample)
CO (1) CO5640129A2 (enExample)
EA (1) EA007163B1 (enExample)
HR (1) HRP20040469A2 (enExample)
HU (1) HUP0402486A3 (enExample)
IL (1) IL161578A0 (enExample)
MX (1) MXPA04005123A (enExample)
NO (1) NO20042737L (enExample)
NZ (1) NZ532909A (enExample)
PL (1) PL370515A1 (enExample)
WO (1) WO2003048130A2 (enExample)
ZA (1) ZA200404173B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1662487A (zh) 2002-06-19 2005-08-31 伊莱利利公司 酰胺连接基过氧化物酶体增殖物激活受体调节剂
US7816385B2 (en) * 2002-12-20 2010-10-19 High Point Pharmaceuticals, Llc Dimeric dicarboxylic acid derivatives, their preparation and use
DE10351859A1 (de) * 2003-11-06 2005-06-09 Beiersdorf Ag Emulsionen mit zwei Verdickungsmitteln
EP1734963A4 (en) 2004-04-02 2008-06-18 Merck & Co Inc METHOD FOR TREATING PEOPLE WITH METABOLIC AND ANTHROPOMETRIC DISORDER
US7456164B2 (en) 2004-05-07 2008-11-25 Pfizer, Inc 3- or 4-monosubtituted phenol and thiophenol derivatives useful as H3 ligands
CN101044120B (zh) * 2004-09-28 2011-06-15 阿勒根公司 用作特异性或选择性α2肾上腺素能激动剂的未取代和取代的4-苄基-1,3-二氢-咪唑-2-硫酮及其使用方法
CL2007001794A1 (es) 2006-06-20 2008-01-18 Wyeth Corp Compuestos derivados de 2-imidazolidinona, inhibidores del canal de potasio kv1.5; composicion farmaceutica que los comprende; y su uso para tratar o prevenir arritmias cardiacas. tromboembolia,apoplejia,insuficiencia cardiaca.
FR2903984B1 (fr) * 2006-07-24 2008-10-03 Genfit Sa Derives d'imidazolones substitues, preparation et utilisations
WO2008094860A2 (en) 2007-01-30 2008-08-07 Allergan, Inc. Treating ocular diseases using peroxisome proliferator-activated receptor delta antagonists
MX354786B (es) 2007-06-04 2018-03-21 Synergy Pharmaceuticals Inc Agonistas de guanilato ciclasa utiles para el tratamiento de trastornos gastrointestinales, inflamacion, cancer y otros trastornos.
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CA2726917C (en) 2008-06-04 2018-06-26 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2321341B1 (en) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
CN101875636B (zh) * 2010-05-18 2012-01-04 浙江大学 咪唑啉-2,4-二酮类衍生物及制备方法和用途
WO2012027331A1 (en) 2010-08-27 2012-03-01 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
JP2016514671A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼのアゴニストおよびその使用
CN105764916B (zh) 2013-06-05 2021-05-18 博士医疗爱尔兰有限公司 鸟苷酸环化酶c的超纯激动剂、制备和使用所述激动剂的方法
CN115894379B (zh) * 2022-01-20 2025-06-27 哈尔滨三联药业股份有限公司 海因类化合物及其医药用途
CN114835655A (zh) * 2022-04-14 2022-08-02 河南师范大学 一种合成光学活性三氟甲基丙烯酸酯类化合物的方法
WO2026013449A2 (en) * 2024-07-11 2026-01-15 Sea4Us - Biotecnologia E Recursos Marinhos, Sa Oxazolidone-derived compounds and their use in the treatment of chronic and acute pain

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3452041A (en) 1965-05-19 1969-06-24 American Home Prod Hydantoin compounds and methods of preparation
DK244577A (da) 1976-06-03 1977-12-04 Wellcome Found Fremgangsmade til fremstilling af hydantoinderivater
GB1601310A (en) * 1978-05-23 1981-10-28 Lilly Industries Ltd Aryl hydantoins
JPS59159163A (ja) * 1983-03-01 1984-09-08 Fuji Photo Film Co Ltd ハロゲン化銀カラ−感光材料
GB9604242D0 (en) * 1996-02-28 1996-05-01 Glaxo Wellcome Inc Chemical compounds
EP0966447B1 (en) * 1997-03-03 2003-03-05 Boehringer Ingelheim Pharmaceuticals Inc. Small molecules useful in the treatment of inflammatory disease
AU7073400A (en) * 1999-08-27 2001-03-26 Eli Lilly And Company Biaryl-oxa(thia)zole derivatives and their use as ppars modulators

Similar Documents

Publication Publication Date Title
JP2005517643A5 (enExample)
JP2005053931A5 (enExample)
JP2007508359A5 (enExample)
JP2006524222A5 (enExample)
JP2008510828A5 (enExample)
JP2007524696A5 (enExample)
JP2002543183A5 (enExample)
JP2002520309A5 (enExample)
JP2012510502A5 (enExample)
JP2005513123A5 (enExample)
WO2002038553A3 (en) Triazole derivatives and their use as peroxisome proliferator activated receptor alpha agonists
JPWO2022256806A5 (enExample)
JP2007534702A5 (enExample)
RU2011152891A (ru) Диарилгидантоины
JP2002543185A5 (enExample)
JP2005112864A5 (enExample)
JP2006509842A5 (enExample)
HRP20070430T3 (en) (3-oxo-3,4-dihydro-quinoxalin-2-yl-amino)-benzamide derivatives and related compounds as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity
RU2006137272A (ru) Производные 2-фенилпропионовой кислоты и содержащие их фармацевтические композиции
JP2004517813A5 (enExample)
JP2008546770A5 (enExample)
JP2007510662A5 (enExample)
JP2005525392A5 (enExample)
JP2005517008A5 (enExample)
JP2007519618A5 (enExample)